Trond Erik Aune

Dr. Trond Erik Vee Aune earned his Ph.D. in molecular biology at the Norwegian University of Science and Technology in 2008 for his work on recombinant protein production in E. coli. His main focus was on how to optimize the xylS/Pm expression system for increased titres through directed evolution of the XylS transcription regulator. Dr. Aune then co-founded Vectron Biosolutions AS together with his colleague Professor Svein Valla. The company's core technology is the VB expression system for industrial production of proteins in E. coli and other bacteria. This technology can be used to increase the yields and solubility of therapeutic proteins significantly, and thus lower the manufacturing costs of many biopharmaceutical products. Dr. Aune is now chief executive officer in Vectron Biosolutions AS.